News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Elie G. Dib: TAPUR study has been presented at the 2024 ASCO Annual Meeting!
ihacares.com
Jun 6, 2024, 14:04

Elie G. Dib: TAPUR study has been presented at the 2024 ASCO Annual Meeting!

Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital, posted on LinkedIn:

“Exciting News!

I’m thrilled to share that TAPUR study on the antitumor activity of Pertuzumab and Trastuzumab in advanced solid tumors with ERBB2/3 alterations has been presented at the 2024 ASCO Annual Meeting!

This research, conducted with the incredible team at Trinity Health MI (Ann Arbor) and other sites across the nation, shows promising results with a disease control rate of 57% and an objective response rate of 29%.

Onward to more advancements in cancer treatment!”

Elie G. Dib

Additional information.
Source: Elie G. Dib/LinkedIn

Abby Gregory Ajjai Shivaram Alva Allison Paige Watson American Society for Clinical Oncology Ann Arbor ASCO ASCO24 cancer treatment Carmen Julia Calfa Deepti Behl Elie G. Dib Elizabeth Garrett-Mayer ERBB2/3 Eugene Ahn Evthokia Hobbs Funda Meric-Bernstam Kathleen J Yost Mehmet Akce Meredith McKean Michael Rothe Navid Hafez Pam K. Mangat pertuzumab Ramya Thota Richard L. Schilsky Saint Joseph Mercy Hospital Susan Halabi TAPUR study Timothy Lewis Cannon trastuzumab Trinity Health MI
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues